This study developed and validated a dynamic nomogram model that integrates clinicopathological features (e.g., sex, histology, EGFR status, CEA, NSE) and immune biomarkers (e.g., ALC and PD-L1 expression) for predicting the risk of BM in stage…
Development and validation of a dynamic nomogram for predicting brain metastasis in stage III NSCLC patients undergoing definitive chemoradiotherapy | BMC Cancer
